Comparative uptake, retention and cytotoxicity of daunorubicin by human myeloid cells
- 1 April 1986
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 35 (7) , 1185-1190
- https://doi.org/10.1016/0006-2952(86)90158-9
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Daunorubicin reductase activity in human normal lymphocytes, myeloblasts and leukemic cell linesEuropean Journal of Cancer and Clinical Oncology, 1985
- Uptake and metabolism of daunorubicin by human myelocytic cellsCancer Chemotherapy and Pharmacology, 1985
- Quantitation of daunorubicin and its metabolites by high-performance liquid chromatography with electrochemical detectionJournal of Chromatography B: Biomedical Sciences and Applications, 1982
- Comparative nuclear and cellular incorporation of daunorubicin, doxorubicin, carminomycin, marcellomycin, aclacinomycin A and AD 32 in daunorubicin-sensitive and-resistant Ehrlich ascites in vitroZeitschrift für Krebsforschung und Klinische Onkologie, 1980
- Subcellular localization of daunorubicin in sensitive and resistant Ehrlich ascites tumor cellsPublished by Elsevier ,1980
- Uptake and retention of adriamycin and daunorubicin by sensitive and anthracycline-resistant sublines of P388 leukemiaBiochemical Pharmacology, 1978
- Transport and binding of daunorubicin, adriamycin, and rubidazone in ehrlich ascites tumour cellsBiochemical Pharmacology, 1977
- AdriamycinAnnals of Internal Medicine, 1974
- Active outward transport of daunomycin in resistant ehrlich ascites tumor cellsBiochimica et Biophysica Acta (BBA) - Biomembranes, 1973
- Inhibitors of an RNA‐dependent DNA polymeraseFEBS Letters, 1971